Superdrug, one of the leading health and beauty retailers, is all set to invest in 25 new stores this year, expanding its bricks-and-mortar retail footprint.
It confirmed with Pharmacy Business that amongst its 25 new stores there "will be a mix of pharmacy and retail stores".
The venture is expected to create over 570 jobs nationwide, creating a seamless customer experience and providing vital support for high streets and local
communities.
The investment, part of the brand's O+O (Online + Offline) platform strategy to deliver its omnichannel ambitions, is driven by continued strong performance
figures. In Q4 2022 Superdrug reported increased volume and value sales and footfall across both sides of the beauty and health business. Whilst in 2021 revenue
rose 5.1% to £1,168million with a profit before tax increase of 141.3%.
The investment strategy has already seen Superdrug open new stores in Washington Gallery and Falkirk Retail Parks in February 2023 and in Braehead, the largest
Superdrug in Scotland, just last month.
The renowned health and beauty chain has announced impressive annual sales and profit figures, following the expansion of its British high street estate.
According to a report by The Times, Superdrug's pre-tax profits jumped by 43.6 per cent to £111.6 million in the year ending December 2023 compared to the previous
year.
The company's revenue also experienced significant growth, rising by 11.8 per cent to reach £1.52 billion, marking its third consecutive year of market share growth.
Key factors driving this growth include the opening of 14 new stores across strategic locations such as The Trafford Centre in Manchester and Brent Cross shopping
centre in north London, and the refitting of 45 stores last year.
Additionally, the continued expansion of its cheaper, own-label products, along with exclusive launches from brands like Bioré SPF, Nyx X Barbie, and Billie Eilish
fragrances, significantly contributed to a 4.2 per cent year-on-year increase in Superdrug's sales volume.